BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qie S, Sang N. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. J Exp Clin Cancer Res 2022;41:161. [PMID: 35501821 DOI: 10.1186/s13046-022-02370-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Z, Shen X, Wei Y, Chen Y, Chai H, Xia L, Leng W. A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2). Front Genet 2022;13:927046. [DOI: 10.3389/fgene.2022.927046] [Reference Citation Analysis]